As European manufacturers localize their supply chains and production, they are also warning that drug prices could creep up if the European Commission doesn’t provide …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
A new study published in Nature Genetics by the Lymphoid Development Group at the MRC Laboratory of Medical Sciences has reveals that the contribution of
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hey there. We await